Home › NDC Lookup › RxCUI directory › RxCUI 2740413

3 ML insulin icodec-abae 700 UNT/ML Pen Injector [Awiqli] — RxCUI 2740413

Name: 3 ML insulin icodec-abae 700 UNT/ML Pen Injector [Awiqli] (RxCUI 2740413)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2740413 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2740413

Official name3 ML insulin icodec-abae 700 UNT/ML Pen Injector [Awiqli]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as3 ML Awiqli 700 UNT/ML Pen Injector; Awiqli 2100 UNT in 3 ML Pen Injector; Awiqli 2100 UNT per 3 ML Pen Injector

FDA products mapped3

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 3 ML insulin icodec-abae 700 UNT/ML Pen Injector... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 3 ML insulin icodec-abae 700 UNT/ML Pen Injector [Awiqli] RxCUI 2740413 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Insulin icodec 2740394 IN
- Insulin icodec-abae 2740395 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Awiqli 2740403 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Insulin icodec Pen Injector 2740398 SCDF
- Insulin icodec-abae Pen Injector 2740400 SCDFP
- Insulin icodec Injectable Product 2740397 SCDG
- Insulin icodec-abae Injectable Product 2740399 SCDGP
- Insulin icodec Pen Injector [Awiqli] 2740406 SBDF
- Insulin icodec-abae Pen Injector [Awiqli] 2740407 SBDFP
- Awiqli Injectable Product 2740405 SBDG
- Pen Injector 1649571 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 3 ML insulin icodec-abae 700 UNT/ML Pen Injector 2740412 SCD
- Insulin icodec-abae 700 UNT/ML 2740396 SCDC
- Insulin icodec-abae 700 UNT/ML [Awiqli] 2740404 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

3 ML insulin icodec-abae 700 UNT/ML Pen Injector SCD · 2740412
Insulin icodec-abae 700 UNT/ML SCDC · 2740396
Insulin icodec Pen Injector SCDF · 2740398
Insulin icodec-abae Pen Injector SCDFP · 2740400
Insulin icodec Injectable Product SCDG · 2740397
Insulin icodec-abae Injectable Product SCDGP · 2740399

Brand-Name Concepts

Insulin icodec-abae 700 UNT/ML [Awiqli] SBDC · 2740404
Insulin icodec Pen Injector [Awiqli] SBDF · 2740406
Insulin icodec-abae Pen Injector [Awiqli] SBDFP · 2740407
Awiqli Injectable Product SBDG · 2740405
Awiqli BN · 2740403

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2740413 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00169-3105-11	1 SYRINGE in 1 CARTON (0169-3105-11) / 1.5 mL in 1 SYRINGE...	Awiqli	Novo Nordisk	2026-03-26
00169-3121-13	1 SYRINGE in 1 CARTON (0169-3121-13) / 3 mL in 1 SYRINGE (0...	Awiqli	Novo Nordisk	2026-03-26
00169-3170-97	1 SYRINGE in 1 CARTON (0169-3170-97) / 1 mL in 1 SYRINGE (0...	Awiqli	Novo Nordisk	2026-03-26

Observed labelers: Novo Nordisk (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.